Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

OncoCyte Corporation

3.20
0.0000
Volume:- -
Turnover:318.43K
Market Cap:91.52M
PE:-0.96
High:3.20
Open:3.20
Low:3.20
Close:3.20
52wk High:4.75
52wk Low:1.92
Shares:28.60M
Float Shares:7.76M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3429
EPS(LYR):-4.6612
ROE:-428.96%
ROA:-22.17%
PB:8.96
PE(LYR):-0.69

Loading ...

OverviewCompanyNewsFilings

Oncocyte Price Target Maintained With a $4.25/Share by Needham

Dow Jones
·
Apr 08

Oncocyte Files Secondary Stock Shelf

MT Newswires Live
·
Apr 01

Oncocyte Price Target Maintained With a $4.00/Share by Stephens & Co.

Dow Jones
·
Mar 25

OncoCyte Corp expected to post a loss of 43 cents a share - Earnings Preview

Reuters
·
Mar 22

OncoCyte to Release Fourth Quarter 2024 Results on March 24, 2025

THOMSON REUTERS
·
Mar 19

Oncocyte Prices $29 Million Stock Offerings

MT Newswires Live
·
Feb 11

OncoCyte Prices $29.1 Million Equity Offering

THOMSON REUTERS
·
Feb 10

OncoCyte Corp: Proceeds Expected to Fund Transplant Assay Through FDA Ivd Clearance and Commercial Launch

THOMSON REUTERS
·
Feb 10

OncoCyte Appoints DR. Paul Billings as Consulting Chief Medical Officer

THOMSON REUTERS
·
Jan 08

Press Release: Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Dow Jones
·
Jan 08

Analyst Rate

Buy
Buy
50.00%
Hold
50.00%
Sell
0.00%

Corporate Actions

Symbol Change
Jun 18, 2025 IMDX
Financial Report Announcement
May 12, 2025 Post Market
Financial Report Announcement
Mar 24, 2025 Post Market
Financial Report Announcement
Nov 12, 2024 Post Market
Financial Report Announcement
Aug 08, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.96
Current
-3.93
Sector Average
56.35%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.96
Maximum
-0.32
+1 STD
1.18
Minimum
-20.27
-1 STD
-9.05
Average
-3.93

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.